Patients with NAFLD alone had higher SBP, DBP, BMI, and HOMA-IR values, higher serum ALT, triglyceride, fasting insulin, leptin, hs-CRP, and IP-10 levels, and lower HDL-C level than control subjects. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.